MTMarie Trkova

Marie Trkova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marie Trkova has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Zdenek Sedlacek

    Department of Biology and Medical Genetics, Charles University 2nd Medical School and University Hospital Motol, Prague, Czech Republic

    2 shared publications
  • David Sumerauer

    Department of Pediatric Hematology and Oncology, Charles University 2nd Medical School and University Hospital Motol, Prague, Czech Republic

    1 shared publication
  • Jaroslav Mares

    Institute of Biology and Medical Genetics, Charles University Second Medical School, V uvalu 84, 15006 Prague, Czech Republic

    1 shared publication
  • Jaroslava Dušková

    Institute of Pathology, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic

    1 shared publication
  • Kamila Prochazkova

    Department of Biology and Medical Genetics, Charles University 2nd Medical School and University Hospital Motol, Prague, Czech Republic

    1 shared publication
  • Lucie Benesova

    Centre for Applied Genomics of Solid Tumors (CEGES), Genomac Research Institute, Drnovská 1112/60, 161 00 Prague, Czech Republic

    1 shared publication

Latest Publications

  • Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age

    by Marie Trkova, Kamila Prochazkova, Vera Krutilkova, David Sumerauer, Zdenek Sedlacek

    BACKGROUND.: A decrease in the age at cancer onset and increase in cancer incidence in successive generations in Li‐Fraumeni syndrome (LFS) families with germline TP53 mutations have been previously described. In the current study a possible relation was analyzed between telomere length and cancer onset in TP53 mutation carriers.METHODS.: Telomere length was measured using real‐time quantitative polymerase chain reaction (PCR) in 20 carriers of germline TP53 mutations and in 83 unrelated healthy individuals. According to the age at blood sampling, patients and controls were divided into 2 age groups, children and adults. Telomere length was correlated to TP53 mutation status and telomere shortening in patients to the age at cancer onset. A t‐test and linear regression were used to analyze the data.RESULTS.: Compared with healthy controls, telomere length was significantly shorter both in the child (P = .001) and adult (P = .034) germline T53 mutation carriers. Although a statistically significant correlation between telomere shortening and the age at cancer onset was not observed, there was a trend of shorter telomeres in mutation carriers affected in childhood compared with those affected later in life. Neither cancer therapy nor sex differences were likely to affect the results.CONCLUSIONS.: The findings suggest a possible link between the carriership of a germline TP53 mutation, telomere length, predisposition to early‐onset cancer, and anticipation in LFS. Cancer 2007. © 2007 American Cancer Society.


  • Analysis of genetic events in 17p13 and 9p21 regions supports predominant monoclonal origin of multifocal and recurrent bladder cancer

    by Marie Trkova, Marko Babjuk, Jaroslava Duskova, Lucie Benesova-Minarikova, Viktor Soukup, Jaroslav Mares, Marek Minarik, Zdenek Sedlacek


  • Is there anticipation in the age at onset of cancer in families with Li-Fraumeni syndrome?

    by Marie Trkova, Marie Hladikova, Pavel Kasal, Petr Goetz, Zdenek Sedlacek

    Anticipation in the age at onset of cancer in successive generations was described in several familial cancer syndromes. Based on multiple statistical analyses of a database of families with germline TP53 mutations, and using several different approaches and measures to eliminate possible biases, we show that anticipation may be a feature of the Li-Fraumeni syndrome. Definitive proof of anticipation in pedigrees with germline TP53 mutations will require more family data and further analysis, as well as research on the role of the p53 protein in processes like genome stability, which may represent the biological basis of anticipation in these families. This should have important practical implications for genetic testing, counselling, and preventative care for individuals at risk.